Orforglipron is a small-molecule GLP-1 receptor agonist designed for oral administration. By activating the GLP-1 receptor, it is intended to support weight management and improve metabolic health.
Orforglipron is a small-molecule GLP-1 receptor agonist designed for oral administration. By activating the GLP-1 receptor, it is intended to support weight management and improve metabolic health.
Synthetic
metabolism, Weight Management
3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
C48H48F2N10O5